1103738-17-5

Basic information

• Product Name: α-L-Xylofuranuronic acid, 1,2-O-(1-Methylethylidene)-
• Synonyms: α-L-Xylofuranuronic acid, 1,2-O-(1-Methylethylidene)-;(3aS,5R,6S,6aS)-6-Hydroxy-2,2-dimethyl-tetrahydro-2H-furo[2,3-d][1,3]dioxole-5-carboxylic acid;EOS-61340
• CAS NO: 1103738-17-5
• Molecular Formula: C₈H₁₂O₆
• Molecular Weight: 204.17728
• Mol File: 1103738-17-5.mol
• Article Data: 10

Chemical Properties

• Boiling Point: 399.5±42.0 °C(Predicted)
• Appearance: /
• Density: 1.420±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 2.96±0.60(Predicted)
• CAS DataBase Reference: α-L-Xylofuranuronic acid, 1,2-O-(1-Methylethylidene)-(CAS DataBase Reference)
• NIST Chemistry Reference: α-L-Xylofuranuronic acid, 1,2-O-(1-Methylethylidene)-(1103738-17-5)
• EPA Substance Registry System: α-L-Xylofuranuronic acid, 1,2-O-(1-Methylethylidene)-(1103738-17-5)

Safety Data

• Hazardous Substances Data: 1103738-17-5(Hazardous Substances Data)

Usage

General Description

α-L-Xylofuranuronic acid, 1,2-O-(1-Methylethylidene)- is a chemical compound that belongs to the class of organic compounds known as pentose and Pentosulose carboxylic acids. It is a uronic acid derivative with a methylethylidene group attached to the C2 position of α-L-Xylofuranuronic acid. α-L-Xylofuranuronic acid, 1,2-O-(1-Methylethylidene)- is commonly used in the synthesis of complex carbohydrates and glycosylated structures. It possesses potential biological activities and can serve as a useful tool in chemical and biochemical research. Additionally, it has applications in the food and pharmaceutical industries for the development of novel products.

Upstream product

• 1352955-16-8 (3aS,5R,6S,6aS)-5-hydroxymethyl-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxolane-6-ol 
• 108-21-4 Isopropyl acetate 
• 41546-31-0 L-xylose 
• 87-72-9 D-Xylose 
• 131156-47-3 (3aS,3bR,7aS,8aS)-2,2,5,5-tetramethyltetrahydro-3aH-[1,3]dioxolo[4',5':4,5]furo[3,2-d][1,3]dioxane 
• 609-06-3 L-xylose 
• 114861-22-2 1,2-O-isopropylidene-α-L-xylofuranose 

Downstream Products

• 1103738-19-7 ((3aS,5R,6S,6aS)-6-hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)(morpholin-4-yl)methanone 
• 1103738-20-0 morpholine (3aS,5R,6S,6aS)-6-hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxole-5-carboxylic acid 
• 1103738-30-2 (4-chloro-3-(4-ethoxybenzyl)phenyl)((3aS,5R,6S,6aS)-6-hydroxy-2,2-dimethyltetrahydrofuran[2,3-d][1,3]dioxolan-5-yl)methanone 
• 1018898-84-4 acetic acid (3S,4R,5S,6S)-2,4,5-triacetoxy-6-[4-chloro-3-(4-ethoxy-benzyl)-phenyl]-tetrahydropyran-3-yl ester 
• 864070-44-0 empagliflozin 
• 1018899-04-1 (2S,3R,4R,5S,6R)-2-[4-chloro-3-(4-ethoxybenzyl)phenyl]-6-(methylsulfanyl)tetrahydro-2-H-pyran-3,4,5-triol 

Relevant articles and documents

METHOD FOR PRODUCING DIPHENYLMETHANE DERIVATIVE

The present invention relates to an improved method for producing a diphenylmethane derivative which is effective as a sodium-dependent glucose cotransporter (SGLT) inhibitor, the method being carried out by means of a convergent synthesis method in which

6-halogenated glucose C-glycoside as well as preparation method and application thereof

The invention discloses a 6-halogenated glucose C-glycoside as well as a preparation method and application thereof. A structure of 6-halogenated glucose C-glycoside is shown in formula I; an intermediate can be synthesized efficiently with cheap and easily available raw materials; meanwhile, when the raw material is used for synthesizing Jardiance, dapagliflozin and the like, a reaction yield ishigh, and an obtained product has high purity and relatively high industrial application prospect.

Glucopyranosyl derivative and application thereof in medicine

The invention relates to a glucopyranosyl derivative as a sodium-dependent glucose transporter (SGLT) inhibitor, a pharmaceutical composition containing the derivative and an application thereof in medicine, and in particular to the glucopyranosyl derivative as shown in a formula (I) or a pharmaceutically acceptable salt or all stereisomers thereof, or use of the pharmaceutical composition containing the derivative and the derivative and the pharmaceutical composition for preparing medicines treating diabetes and diabetes related diseases.